Commentary calls for decoupling pathogen data access from benefit-sharing obligations in the WHO Pandemic Agreement’s PABS Annex to ensure equitable global health responses.
Advocacy for Delinking Data Access and Benefit Sharing
As negotiations on the WHO Pandemic Agreement’s Pathogen Access and Benefit-Sharing (PABS) Annex remain stalled, a recent policy intervention argues for delinking access to pathogen data from benefit-sharing obligations. The current draft ties data sharing to downstream commercial benefits, creating potential disincentives for timely reporting during outbreaks.
The proposal, drawing from models advanced by Knowledge Ecology International (KEI), suggests treating data access as a public good, independent of profit-sharing arrangements. This would allow rapid scientific collaboration without legal friction over future royalties or vaccine-sharing commitments.
If adopted, such a framework could enhance global pandemic preparedness. For Indian policymakers and legal practitioners, the debate highlights the need to balance sovereign rights over genetic resources with obligations under international health regulations and TRIPS. India may leverage this discourse to advocate for equitable frameworks in future health treaties.
